Ceritinib in Patients (PTS) with Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Metastatic to the Brain and/or Leptomeninges: the Phase II Ascend-7 Study
Titel:
Ceritinib in Patients (PTS) with Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC) Metastatic to the Brain and/or Leptomeninges: the Phase II Ascend-7 Study
Auteur:
Chow, L.Q. Barlesi, F. Bertino, E.M. Kim, D.-W. van den Bent, M.J. Wakelee, H. Wen, P.Y. Cazorla Arratia, P. Shen, J. Branle, F.